7Baggers
 Scholar Rock stock price target raised to $50 from $45 at BMO Capital  Investing.com Mon, 17 Nov 2025 14:03:00 GMT
 FDA meeting sets path for resubmission of apitegromab for SMA  SMA News Today Mon, 17 Nov 2025 13:23:54 GMT
 Scholar Rock price target raised to $45 from $44 at Barclays  TipRanks Mon, 17 Nov 2025 10:25:28 GMT
 Scholar Rock (NASDAQ:SRRK) Issues Earnings Results  MarketBeat Mon, 17 Nov 2025 00:04:40 GMT
 Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses  Yahoo! Finance Canada Sun, 16 Nov 2025 16:16:28 GMT
 Published on: 2025-11-15 17:09:12  newser.com Sat, 15 Nov 2025 23:09:12 GMT
 Published on: 2025-11-15 14:51:42  newser.com Sat, 15 Nov 2025 20:51:42 GMT
 Scholar Rock (NASDAQ:SRRK) Shares Gap Up - Still a Buy?  MarketBeat Sat, 15 Nov 2025 16:42:40 GMT
 why did scholar rock soar 26% today?  MSN Sat, 15 Nov 2025 12:28:30 GMT
 Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress  Yahoo! Finance Canada Sat, 15 Nov 2025 12:07:26 GMT
 published on: 2025-11-15 05:08:58  newser.com Sat, 15 Nov 2025 11:08:58 GMT
 published on: 2025-11-15 02:50:59  newser.com Sat, 15 Nov 2025 08:50:59 GMT
 Decoding Scholar Rock Holding Corp (SRRK): A Strategic SWOT Insi  GuruFocus Sat, 15 Nov 2025 05:09:22 GMT
 Scholar Rock Advances SMA Treatment Amid Financial Losses  TipRanks Sat, 15 Nov 2025 04:09:28 GMT
 TD Cowen Maintains Scholar Rock(SRRK.US) With Buy Rating  富途牛牛 Fri, 14 Nov 2025 23:31:00 GMT
 Scholar Rock Stocks Rise: Analyzing Key Catalysts  timothysykes.com Fri, 14 Nov 2025 22:05:00 GMT
 Published on: 2025-11-14 14:01:29  newser.com Fri, 14 Nov 2025 20:01:29 GMT
 Why Is Scholar Rock Holding Stock Climbing Today?  Benzinga Fri, 14 Nov 2025 18:49:11 GMT
 Scholar Rock price target raised to $50 from $45 at BMO Capital  TipRanks Fri, 14 Nov 2025 18:28:10 GMT
 scholar rock q3 2025 earnings call transcript  MarketBeat Fri, 14 Nov 2025 18:13:37 GMT
 Why Did Scholar Rock Soar 26% Today?  MSN Fri, 14 Nov 2025 17:45:00 GMT
 Scholar Rock (SRRK) Surges Over 25% in Stock Price  GuruFocus Fri, 14 Nov 2025 17:44:31 GMT
 Earnings call transcript: Scholar Rock Q3 2025 sees stock surge amid mixed results  Investing.com Nigeria Fri, 14 Nov 2025 16:08:42 GMT
 Scholar Rock reports Q3 EPS (90c), consensus (84c)  TipRanks Fri, 14 Nov 2025 16:07:38 GMT
 Scholar Rock (SRRK) Surges Nearly 29% Following Market Activity  GuruFocus Fri, 14 Nov 2025 16:02:57 GMT
 Scholar Rock Leans Into Losses Ahead Of Apitegromab Launch  Finimize Fri, 14 Nov 2025 15:27:43 GMT
 Why Scholar Rock’s Stock is Facing Challenges  TipRanks Fri, 14 Nov 2025 13:29:05 GMT
 Scholar Rock Announces $200M At-The-Market Offering  TipRanks Fri, 14 Nov 2025 13:17:53 GMT
 Scholar Rock (SRRK) Advances Muscle-Targeted Treatment for SMA  GuruFocus Fri, 14 Nov 2025 12:56:29 GMT
 Scholar Rock Holds Constructive FDA Meeting for Apitegromab  TipRanks Fri, 14 Nov 2025 12:32:29 GMT
 Scholar Rock Holding Corp SEC 10-Q Report  TradingView Fri, 14 Nov 2025 12:23:01 GMT
 Drug developer Scholar Rock's Q3 net loss widens  TradingView Fri, 14 Nov 2025 12:08:45 GMT
 BRIEF-Scholar Rock Q3 Net Income USD -102.22 Million  TradingView Fri, 14 Nov 2025 12:00:46 GMT
 published on: 2025-11-13 11:42:47  newser.com Thu, 13 Nov 2025 17:42:47 GMT
 What to Expect from Scholar Rock Holding's Earnings  Benzinga Thu, 13 Nov 2025 14:01:05 GMT
 published on: 2025-11-12 21:55:12  newser.com Thu, 13 Nov 2025 03:55:12 GMT
 3 beaten-down stocks with rebound potential this earnings season  The Globe and Mail Wed, 12 Nov 2025 13:07:30 GMT
 scholar rock (srrk) to release earnings on friday  MarketBeat Fri, 07 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 09:59:00  newser.com Wed, 05 Nov 2025 15:59:00 GMT
 published on: 2025-11-02 22:36:16  newser.com Mon, 03 Nov 2025 03:36:16 GMT

Scholar Rock Holding Corporation
(NASDAQ:SRRK) 

SRRK stock logo

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, a novel inhibitor of the activation of l...

Founded: 2012
Full Time Employees: 93
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends